Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans.
complex case discussions
decision support
oncology pathways
personalized medicine
subspecialty expertise
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
14 Nov 2022
14 Nov 2022
Historique:
received:
29
09
2022
revised:
09
11
2022
accepted:
09
11
2022
entrez:
26
11
2022
pubmed:
27
11
2022
medline:
27
11
2022
Statut:
epublish
Résumé
The complexity of cancer care requires integrated and continuous support to deliver appropriate care. An expert network with complementary expertise and the capability of multidisciplinary care is an integral part of contemporary oncology care. Appropriate infrastructure is necessary to empower this network to deliver personalized precision care to their patients. Providing decision support as cancer care becomes exponentially more complex with new diagnostic and therapeutic choices remains challenging. City of Hope has developed a Pyramidal Decision Support Framework to address these challenges, which were exacerbated by the COVID pandemic, health plan restrictions, and growing geographic site diversity. Optimizing efficient and targeted decision support backed by multidisciplinary cancer expertise can improve individual patient treatment plans to achieve improved care and survival wherever patients are treated.
Identifiants
pubmed: 36431215
pii: jcm11226738
doi: 10.3390/jcm11226738
pmc: PMC9697355
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIH HHS
ID : P30CA033572
Pays : United States
Références
Curr Oncol. 2018 Dec;25(6):378-383
pubmed: 30607112
J Oncol Pract. 2019 Jun;15(6):325-329
pubmed: 30802151
J Oncol Pract. 2017 Apr;13(4):e346-e352
pubmed: 28260402
Can J Urol. 2019 Oct;26(5 Suppl 2):50-51
pubmed: 31629433
Eur J Cancer. 2007 Apr;43(6):1002-10
pubmed: 17329094
Med Care Res Rev. 2009 Oct;66(5):542-60
pubmed: 19454624
J Oncol Pract. 2018 Jul;14(7):e412-e420
pubmed: 29906211
Cancer. 2013 Apr 15;119(8):1593-601
pubmed: 23280510
Pulm Ther. 2021 Dec;7(2):295-308
pubmed: 34089169
J Natl Cancer Inst. 2013 Jan 16;105(2):113-21
pubmed: 23274388
J Clin Med. 2020 Jun 15;9(6):
pubmed: 32549358
JAMIA Open. 2019 Oct 07;2(4):505-515
pubmed: 32025647
Oncotarget. 2018 Jul 6;9(52):29877-29891
pubmed: 30042820
BMC Cancer. 2020 Apr 28;20(1):355
pubmed: 32345242
Am Health Drug Benefits. 2015 Aug;8(Spec Issue):28
pubmed: 26380613
J Natl Cancer Inst. 2020 Oct 1;112(10):1021-1029
pubmed: 31922567
Acad Radiol. 2017 Jan;24(1):107-110
pubmed: 27793581
J Oncol Pract. 2013 May;9(3):e77-80
pubmed: 23942505
Med Educ. 2001 Sep;35(9):867-75
pubmed: 11555225
J Clin Oncol. 2000 Jun;18(11):2327-40
pubmed: 10829054
JAMA. 2018 Aug 7;320(5):469-477
pubmed: 30088010
J Particip Med. 2019 Jul 10;11(3):e13800
pubmed: 33055068
J Clin Pathw. 2018 Jan-Feb;4(1):49-54
pubmed: 31453358
Oncologist. 2017 Feb;22(2):144-151
pubmed: 28179575
J Oncol Pract. 2018 Dec;14(12):761-762
pubmed: 30537460
J Oncol Pract. 2010 Jan;6(1):12-8
pubmed: 20539725
HPB (Oxford). 2012 Aug;14(8):539-47
pubmed: 22762402
BMC Palliat Care. 2020 Jul 21;19(1):112
pubmed: 32693836
J Oncol Pract. 2011 May;7(3 Suppl):52s-9s
pubmed: 21886520
JAMA Netw Open. 2020 Oct 1;3(10):e2019452
pubmed: 33026450
J Oncol Pract. 2017 Mar;13(3):207-210
pubmed: 28282276
Prostate Cancer Prostatic Dis. 2022 Sep;25(3):403-410
pubmed: 34775478
Diagnostics (Basel). 2017 Oct 17;7(4):
pubmed: 29039744
Oncotarget. 2018 Jan 30;9(21):15792-15815
pubmed: 29644010
J Clin Med. 2021 Jan 07;10(2):
pubmed: 33430334
J Oncol Pract. 2014 May;10(3):155-60
pubmed: 24839272
JNCI Cancer Spectr. 2021 Feb 24;5(2):
pubmed: 33860151
JAMA Netw Open. 2021 Jul 1;4(7):e2115675
pubmed: 34241630
J Clin Oncol. 2018 Feb 20;36(6):554-562
pubmed: 29309250
J Natl Cancer Inst. 2020 Jun 1;112(6):557-561
pubmed: 31845965
Clin Lung Cancer. 2018 Jul;19(4):360-370
pubmed: 29576407
J Oncol Pract. 2018 Dec;14(12):e823-e833
pubmed: 30537462
Cancer. 2006 Nov 15;107(10):2346-51
pubmed: 16998942
Oncologist. 2021 Aug;26(8):e1427-e1433
pubmed: 33932247
JCO Oncol Pract. 2022 Jan;18(1):15-22
pubmed: 34255546
Am Soc Clin Oncol Educ Book. 2017;37:460-466
pubmed: 28561660
J Oncol Pract. 2016 Apr;12(4):339-83
pubmed: 26979926
Am Soc Clin Oncol Educ Book. 2014;:e461-6
pubmed: 24857140
Oncologist. 2018 Mar;23(3):328-336
pubmed: 29317551
Clin Lung Cancer. 2017 Nov;18(6):651-659
pubmed: 28479369
J Oncol Pract. 2016 Mar;12(3):261-6
pubmed: 26759491
J Oncol Pract. 2014 Sep;10(5):322-6
pubmed: 25006221
JCO Precis Oncol. 2018 Nov;2:1-11
pubmed: 35135148
JAMA Oncol. 2021 Sep 1;7(9):1283-1284
pubmed: 34196666
Cells. 2021 Apr 17;10(4):
pubmed: 33920536
J Clin Oncol. 2019 May 20;37(15):1305-1315
pubmed: 30964716